Τόμος 16 (2002) – Τεύχος 3 – Άρθρο 5 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 16 (2002) – Issue 3 – Article 5 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Technological Educational Institution of Lamia (TEI), Lamia, Greece

Accepted for publication: 23 November 2002

pharmakonpress[at]pharmakonpress[.]gr

2.    Deltsidou A.: Cocaine abuse in pregnancy. Epitheor. Klin. Farmakol. Farmakokinet. Inter. Ed. 15: 225-232 (2001)

3.    National Institute of Drug and Alcohol Abuse: National pregnancy and health survey-drug use among women delivering live births. MD NCADI Publication no. BKD 192 (1992)

4.    Κοκκέβη A., Στεφάνής Κ.: Τα ναρκωτικά στην Ελλάδα: Η διαχρονική πορεία της χρήσης. Ερευνητικό Πανεπιστημιακό Ινστιτούτο Ψυχικής Υγιεινής, Αθήνα: 71-78, 191-197 (1994)

5.    Lee E.W., D’ Alonzo G.E.: Cigarette smoking, nicotine addiction, and pharmacologic treatment. Arch. Intern. Med. 153: 34-48 (1993)

6.    Youngstrom N.: Fetal alcohol syndrome carries severe deficits. APA Monitor 23(A): 32 (1992)

7.    Βαρώνος Δ.: Ιατρική Φαρμακολογία. Τόμ. Β’, 5η έκδ. σελ. 64, 329-333, 371-376, Γ. Παρισιάνος, Αθήνα, 1987

8.    Κοτρώτσιου-Μπαρμπούτα Ε., Αργυρούδης Ε., Θεοδοσοπούλου Ε.: Φαρμακολογία του πόνου: Οπιοειδή Αγωνιστές και Ανταγωνιστές. Επιθ. Κλιν. Φαρμακολ. Φαρμακοκιν. 19: 85-90 (2001)

9.    Harvey R., Champe P., et al: Pharmacology: Lippincott’s Illustrated Reviews. Pp. 91-95, 101-104, J. B. Lippincott Company, Philadelphia, 1992

10.  Robinson S.E.: Effect of prenatal opioid exposure on cholinergic development. J. Biomed. Sci. 7: 253-257 (2000)

11.  Briggs G.G., Freeman R.K., Yaffe S.J.: Drugs In Pregnancy and Lactation. In: (Mitchell C.W., ed.). A Reference Guide to Fetal and Neonatal Risk. 4th ed. Pp. 112-118, Williams & Wilkins, Baltimore, 1994

12.  Rementeria J.L., Nunag N.N.: Narcotic withdrawal in pregnancy: Stillbirth incidence with a case report. Am. J. Obstet Gynecol. 116: 1152-1156 (1973)

13.  Burnstein Y., Giardina P.J.V., Rausen A.R., et al.: Thrombocytosis and increased circulating platelet aggregates in newborn infants of polydmg abusers. J. Pediatr. 94: 895-889 (1979)

14.  Hanssler L., Roll C.: Increased thrombocyte count in newborn infants of drug-dependent mothers. Clin. Paediatr. 206: 55-58(1994)

15.  Wagner C., Katikaneni L., Cox T., Ryan R.: The impact of prenatal drug exposure on the neonate. Obstet. Gynecol. Clin. North Am. 25(1): 169-194 (1998)

16.  Connaughton J.F., Reeser D., Schut J., Finnegan L.P.: Perinatal addiction. Outcome and management. Am. J. Obstet. Gynecol. 129: 679 (1977)

17.  Kandall S.R., Albin S., Lowinson J., et al.: Deferential effects of maternal heroin and methadone use on birthweight. Pediatrics 58: 681 (1976)

18.  Chasnoff I.J.: Newborn infants with drug withdrawal symptoms. Pediatr. Rev. 9C9: 273 (1988)

19.  Olofsson M., Buckley W., Andersen G.E., et al. Investigation of 89 children born to drug-dependent mothers. I. Neonatal Course. Acta Paediatr. Scand. 72: 403-406 (1983)

20.  Ziegler M., Poustka F., von Loewenich V., Englert E.: Postpartum risk factors in the development of children bom to opiate- addicted mothers; comparison between mothers with and without methadone substitution. Nervenarzt. 71: 730-736 (2000)

21.  Martinez A., Kästner B., Taeusch H.W.: Hyperphagia in neonates withdrawing from methadone. Arch. Dis. Child. Fetal Neonatal Ed. 80(3): F178-82 (1999)

22.  Κίτσιου-Τζέλη Σ.: Παράγοντες Τερατογένεσης και Συγγενείς Ανωμαλίες, σελ. 22-28, 135-160, Αθήνα, 1992

23.  Kaltenbach Κ., Bergelia V., Finnegan L.: Opioid dependence during pregnancy: Effects and Management. Obstet. Gynecol. Clin. North Am. 25: 139-148 (1Θ98)

24.  Finnegan L., Wapner R.J.: Narcotic addiction in pregnancy. In: (Niebyl J.R., ed.) Drug Use in Pregnancy, Lea and Febiger, Philadelphia, 1987

25.  Briggs G.G., Bodendorier T., Freeman R.K., et al.: Drugs in Pregnancy and Lactation. Williams & Wilkins, Baltimore, 1993

26.  Fricker H., Segal S.: Narcotic addiction, pregnancy and newborn. Am. J. Dis. Child. 132: 360-366 (1978)

27.  Jones K.L., Barr G.A.: Opiate withdrawal in the fetal rat: a behavioral profile. Pharmacol. Biochem. Behav. 66: 419-424 (2000)

28.  Wang E.C.: Methadone treatment during pregnancy. J. Obstet. Gynecol. Neonatal. Nurs. 28: 615-622 (1999)

29.  Newman R., Bashkow S., Calko D.: Results of 313 consecutive live births of infants delivered to patients in the New York City Methadone Treatment Program. Am. J. Obstet. Gynecol. 121: 233-237 (1975)

30.  Dashe J.S., Jackson G.L., Olscher D.A., Zane E.H., Wendel E.D.: Opioid detoxification in pregnancy. Obstet. Gynecol. 92: 854-858 (1998)

31.  Cejtin H.E., Mills A., Swift E.L.: Effect of methadone on the biophysical profile. J. Reprod. Med. 41: 819-822 (1996)

32.  Chappel J.N.: Treatment of morphine-type dependence. JAMA 221: 1515 (1972)

33.  Chiriboga C.A.: Cocaine and the fetus: Methodological issue and neurological correlates. In: (Konkol R.J., Olsen G.D., eds) Prenatal Cocaine Exposure, CRC Press, Boca Raton, 1996

34.  Wilson G.S., McCreary R., Kean J., et al.: The development of preschool children of heroin-addicted mothers: A controlled study. Pediatrics 63: 135-141 (1979)

35.  Zhu J.H., Stadlin A.: Prenatal heroin exposure. Effects on development, acoustic startle response, and locomotion in weanling rats. Neurotoxicol. Teratol. 22: 193-203 (2000)

36.  Nunes E.V., Weissman M.M., Goldstein R., et al.: Psychiatric disorders and impairment in the children of opiate addicts: prevalances and distribution by ethnicity. Am. J. Addict. 9: 232-241 (2000)

37.  Finnegan L.P.: Neonatal abstinence. In: (Nelson N., ed.) Current Therapy in Neonatal-Perinatal Medicine. Pp. 262-270, Mosby, St. Louis, 1985

38.  Finnegan L.P., Kaltenbach K.A.: Neonatal abstinence syndrome, ln: (Hoekelman R.A., Friedman S.B., Nelson N.M., eds) Primary Pediatric Care. 2nd ed. Pp. 1367, Mosby, St. Louis, 1992

39.  Konkol R.J., Olsen G.C. (editorial): Prenatal Cocaine Exposure. CRC Press, Boca Raton, 1996

40.  Suresh S., Anand K.J.: Opioid tolerance in neonates: mechanisms, diagnosis, assessment, and management. Semin. Perinatol. 22: 425-33 (1998)

41.  Αναγνωστάκης Δ., Τρίκκα Π.: Γυναίκες που παίρνουν ηρωίνη στην εγκυμοσύνη και τα νεογέννητα παιδιά τους. Ιατρική 60: 372-375 (1991)

42.  Ostrea Ε.Μ., Chavez C.J.: Perinatal problems (excluding neonatal withdrawal) in maternal drug addiction: A study of 830 cases. J. Pediatr. 94: 292-295 (1979)

43.  Bennett A.D.: Perinatal substance abuse and the drug-ex-posed neonate, Nurse Pract. 7(5): 32-36; quiz 37-38 (1999)

44.  Zelson C., Rubio E., Wasserman E.: Neonatal narcotic addiction: 10 year observation. Pediatrics 48: 178-189 (1971)

45.  Fulroth R.t Phillips B., Duranc D.J.: Perinatal outcomes of infants exposed to cocaine and/ or heroin in utero. Am. J. Dis. Child. 143: 905-910 (1989)

46.  Kandall S.R., Gaines J., Habel L., et al.: Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring. J. Pediatr. 123: 120-126 (1993)

47.  Ward R.M.: Drug therapy of the fetus. J. Clin. Pharmacol. 33: 780-789(1993)

48.  Bunikowski R., Grimmer I., Heiser A., et al.: Neurodevelopmentat outcome after prenatal exposure to opiates. Eur. J. Pediatr. 157: 724-730 (1998)

49.  Malanga C.J., Kosofsky B.E.: Mechanisms of action of drugs of abuse on the developing fetal brain. Clin. Perinatoi. 26: 17-37 (1999)

50.  Van Baar A., de Graaff B.M.T.: Cognitive development and preschool-age of infants of drug-dependent mothers. Developm. Med. Child Neurol. 36: 1063-1075 (1994)

51.  Stichler J.F., Weiss M., Wight N.E.: Examining the ’cost’ of substance abuse in pregnancy: patient outcomes and resource utilization. J. Perinatol. 18: 384-388 (1998)

52.  Blondel S., Lefebvre P., Tondeur M., Blum D.: [Neonatal abstinence syndrome: current and future aspects]. Rev. Med. Brux. 14(3): 73-77 (1993)

53.  Sarman I.: Methadone treatment during pregnancy and its effect on the child. Better than continuing drug abuse, should be monitored by a specialized antenatal care center. Lakartidningen 97: 2182-4, 2187-2188, 2190 (2000)

54.  Agarwal P., Rajadurai V.S., Bhavani S., Tan K.W.: Perinatal drug abuse in KK Women’s and Children’s Hospital. Ann. Acad. Med. Singapore 28: 795-799 (1999)

55.  Schneider C., Fischer G., Diamant K., Hauk R., Pezawas L., Lenzinger E., Kasper S.: Pregnancy and drug dependence. Wien. Klin. Wochenschr. AQ8: 611-614 (1996)

56.  Lejeune C., Floch-Tudal C., Montamat S., et al.: Management of drug addict pregnant women and their children. Arch. Pediatr. 4: 263-270 (1997)

57.  Habbick B.: Fetal alcohol syndrome in Saskatchewan: unchanged incidence in a 20-year period. Can. J. Public Health 87: 204-207 (1996)

58.  Cayol V., Corcos M., Clervoy P., Speranza M.: Pregnancy and drug abuse: current situation and therapeutic strategies. Ann. Med. Interne (Paris) 151(Suppl B): 20-26 (2000)

59.  Kelly J.J., Davis P.G., Henschke P.N.: The drug epidemic: effects on newborn infants and health resource consumption at a tertiary perinatal centre. J. Paediatr. Child Health 36: 262-264 (2000)

60.  Kenner C., D’Apolito Κ.: Outcomes for children exposed to drugs in utero. J. Obstet. Gynecol. Neonatal. Nurs. 26: 595-603 (1997)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr